Stevens Capital Management LP Takes $822,000 Position in Agilent Technologies, Inc. $A

Stevens Capital Management LP bought a new position in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,041 shares of the medical research company’s stock, valued at approximately $822,000.

Several other large investors also recently bought and sold shares of A. Flynn Zito Capital Management LLC raised its holdings in shares of Agilent Technologies by 3.2% in the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after buying an additional 69 shares during the last quarter. Forum Financial Management LP grew its holdings in shares of Agilent Technologies by 2.5% during the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock valued at $375,000 after buying an additional 70 shares during the last quarter. Gabelli Funds LLC increased its position in shares of Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after acquiring an additional 74 shares during the period. Fiduciary Trust Co increased its position in shares of Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after acquiring an additional 77 shares during the period. Finally, NorthCrest Asset Manangement LLC raised its stake in Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after acquiring an additional 79 shares during the last quarter.

Analysts Set New Price Targets

A has been the subject of a number of research reports. HSBC initiated coverage on Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. Wells Fargo & Company reduced their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Barclays decreased their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. TD Cowen dropped their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, UBS Group cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Price Performance

Shares of A opened at $117.55 on Wednesday. The business’s 50-day moving average is $116.24 and its two-hundred day moving average is $132.30. The company has a market capitalization of $33.22 billion, a P/E ratio of 25.95, a P/E/G ratio of 2.36 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a fifty-two week low of $104.36 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period last year, the firm earned $1.31 EPS. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were issued a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.